Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Jonathan Graf
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Jonathan Graf
Professor, Medicine. Authored (or co-authored) 27 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Navidea Biopharmaceuticals
- ID
- NCT03938636
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated